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Abstract Acute ischemia followed by prolonged reperfusion has
been shown to induce cardiomyocyte apoptosis. In this report, we
demonstrate that myocardial adaptation to ischemia induced by
repeated cyclic episodes of short-term ischemia each followed by
another short duration of reperfusion reduced cardiomyocyte
apoptosis and DNA fragmentation. This was associated with the
induction of the expression of Bcl-2 mRNA and translocation
and activation of NF-UB. Another transcription factor, AP-1,
remained unaffected by repeated ischemia and reperfusion, but
exhibited significant upregulation by a single episode of 30 min
ischemia followed by 2 h of reperfusion. This activation of AP-1
was inhibited by a scavenger of oxygen free radicals, DMTU.
Thirty minutes ischemia and 120 min reperfusion downregulated
the induction of the expression of Bcl-2 mRNA, but moderately
activated NF-UB binding activity. This was associated with an
increased number of apoptotic cells and DNA fragmentation in
cardiomyocytes which were attenuated by DMTU. The results of
this study indicate that Bcl-2, AP-1 and NF-UB differentially
regulate cardiomyocyte apoptosis mediated by acute ischemia
and prolonged reperfusion.
z 1999 Federation of European Biochemical Societies.
Key words: Bcl-2; AP-1; Nuclear factor UB; Ischemia;
Reperfusion; Heart; Apoptosis ; DNA fragmentation;
Ischemic adaptation
1. Introduction
Recent studies have demonstrated that myocardial ischemia
and reperfusion result in apoptotic cell death in addition to
tissue necrosis [1^4]. Studies from our laboratory indicated
translocation of phosphatidyl serine and phosphatidyl etha-
nolamine, a hallmark for apoptosis, occurs during ischemia,
but apoptosis does not become apparent until hearts are re-
perfused following an ischemic insult [5]. Myocardial adapta-
tion to ischemia induced by repeated cyclic episodes of rever-
sible short periods of ischemia each followed by another short
period of reperfusion was found to be e¡ective in reducing
apoptotic cell death [6].
Reactive oxygen species serve as a trigger for apoptosis in a
variety of cell types [7,8]. A study from our laboratory dem-
onstrated a role of oxygen free radicals in apoptotic cell death
associated with ischemia and reperfusion [9,10]. Another re-
cent study documented that ischemic adaptation translocated
and increased the binding of nuclear transcription factor NF-
UB in heart [11]. NF-UB is a member of the Rel transcription
factor family which is involved in the regulation of stress
defense mechanisms. Since ischemic adaptation was also
found to reduce apoptosis, we speculated a direct role of
NF-UB in apoptosis. AP-1 is another redox-sensitive signaling
molecule which also plays an important regulatory role in
cellular responses to stress induced by external factors includ-
ing UV radiation, phorbol esters, and tumor necrosis factor K
[12]. AP-1 is composed of either homodimers of c-Jun or
heterodimers of c-Jun and c-Fos. The AP-1 binding site is
the TRE (12-O-tetradecanoyl phorbol 13-acetate response el-
ement), and initiates transcription of target genes [13]. Induc-
tion of apoptosis by elevated levels of c-Jun is a crucial event
in growth factor-deprived nerve cells [14]. Stress induced by
ischemia/reperfusion was previously shown to induce the acti-
vation of c-Jun [15,16].
Bcl-2 is an oncogene which inversely regulates apoptosis
[17,18]. A preliminary study from our laboratory showed up-
regulation of BCl-2 by ischemic adaptation [19]. Induction of
Bcl-2 was found to be associated with reduction of apoptotic
cell death and DNA fragmentation. In this study, we inves-
tigated the role of two redox-sensitive transcription factors,
NF-UB and AP-1, and the anti-apoptotic gene, Bcl-2, in myo-
cardial adaptation to ischemia and how these transacting fac-
tors regulate apoptosis during the stress induced by ischemia/
reperfusion.
2. Materials and methods
2.1. Chemicals
p65 antibody was obtained from Santa Cruz Biotechnological Co.,
CA. AP-1 and NF-UB consensus oligonucleotides were purchased
from Promega, Madison, WI. cDNA probe for Bcl-2 was obtained
from Oncor, Gaithersburg, MD. All other chemicals were of high
purity and obtained from Sigma Chemical Co., St. Louis, MO.
2.2. Isolated perfused heart preparation
Sprague Dawley rats weighing about 300 g were anesthetized with
pentobarbital (80 mg/kg, i.p.). After intravenous administration of
heparin (500 IU/kg), the chests are opened, the hearts were rapidly
excised and mounted on a non-recirculating Langendor¡ perfusion
apparatus [5,20]. Retrograde perfusion was established at a pressure
of 100 cm H2O with oxygenated normothermic Krebs-Henseleit bicar-
bonate (KHB) bu¡er with the following ion concentrations (in mM):
118.0 NaCl, 24.0 NaHCO3, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, 1.7
CaCl2, and 10.0 glucose. The KHB bu¡er had been previously equil-
ibrated with 95% O2/5% CO2, pH 7.4 at 37‡C. The hearts were
randomly divided into ¢ve groups. All hearts were allowed to stabilize
for 15 min before any intervention. In group I, hearts were perfused
for 240 min with the KHB bu¡er while for group II, hearts were
perfused for 90 min with the same bu¡er followed by 30 min of
ischemia and 120 min reperfusion. For group III, hearts were preper-
fused for 15 min with KHB bu¡er containing 10 mM DMTU, a
hydroxyl radical scavenger. Hearts of groups IV and V were adapted
by subjecting them a single cycle of 5 min of ischemia followed by
10 min of reperfusion (1UPC) (group IV) or four cyclic episodes of
5 min ischemia and 10 min reperfusion (4UPC) (group V) prior to
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subjecting them to a 30 min ischemia/120 min reperfusion protocol
[11]. At the end of each experiment, hearts were frozen in liquid nitro-
gen and stored at 370‡C until further analysis.
2.3. Determination of Bcl-2, NF-UB and AP-1 activities
2.3.1. AP-1. The oligonucleotide used for AP-1 consisted of the
following sequence: 5P-CGCTTGATGAGTCAGCCGAA-3P. Gel
shift assay was performed according to the manufacturer’s (Promega)
protocol with slight modi¢cation. 32P end labeled oligonucleotide was
incubated in a 10 Wl reaction mixture containing 10 mmol/l Tris-HCl,
pH 7.5, 0.5 mmol/l EDTA, 0.5 mmol/l DTT, 4% glycerol, 50 mmol/l
NaCl, 1 mmol/l MgCl2 and 0.5 Wg poly(dI-dC) and 4.5 Wg of nuclear
extracts for 30 min at room temperature. Parallel competition experi-
ments were also performed using unlabeled oligonucleotide (10^100
molar) which was added to the binding reaction mixture. After incu-
bation, dye was added to the reaction mixture and the complex
formed was separated in 4% polyacrylamide gel (acrylamide:bisacryl-
amide 30:1) by electrophoresis. The gel was subsequently dried and
exposed to Kodak ¢lm at 370‡C.
2.3.2. NF-UB. To determine NF-UB binding activity, nuclear pro-
teins were isolated from the heart according to the method described
previously [11]. In short, about 150 mg of left ventricle from heart
tissue was homogenized in ice-cold Tris-bu¡ered saline (TBS) and
centrifuged at 3000Ug for 5 min at 4‡C. The pellet was resuspended
by gentle pipetting in 1.5 ml of ice-cold hypotonic bu¡er containing 10
mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA,
1 mM DTT, 0.5 mM PMSF, and 1 WM each of aprotinin, pepstatin
and leupeptin. The solution was allowed to swell on ice for 15 min.
After addition of 100 Wl of 10% Nonidet P-40, the tube was vigorously
vortexed for 45 s. This homogenate was centrifuged for 30 s at 4‡C in
a microcentrifuge tube. The supernatant contained the cytoplasmic
protein. The nuclear pellet was resuspended in a solution containing
20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA,
1 mM DTT, 1 mM PMSF and 1 WM each of aprotinin, pepstatin and
leupeptin. The tubes were vigorously shaken at 4‡C for 30 min on a
shaking platform. The extracts were then centrifuged and the super-
natants were stored at 370‡C. Protein concentration was estimated
using the Pierce Protein Assay kit (Pierce Chemical Co., Rockford,
IL).
NF-UB oligonucleotide (AGTTGAGG-GGACTTTCCCAGG) (2.5
Wl [20 ng/Wl]) was labeled using T4 polynucleotide kinase as previously
described [11]. The binding reaction mixture contained in a total vol-
ume of 20.2 Wl, 0.2 Wl DTT (0.2 M), 1 Wl BSA (20 mg/ml), 4 Wl
poly(dI-dC) (0.5 Wg/Wl), 2 Wl bu¡er D, 4 Wl bu¡er F, 2 Wl 32P-oligo
(0.5 ng/Wl) and 7 Wl extract containing 10 Wg protein. The composition
of bu¡er D was 20 mM HEPES, pH 7.9, 20% glycerol, 100 mM
KCl, 0.5 mM EDTA, 0.25% Nonidet P-40 while bu¡er F contained
20% Ficoll 400, 100 mM HEPES, pH 7.9, and 300 mM KCl. Incu-
bation was carried out for 20 min at room temperature. 10 Wl of the
solution was loaded onto a 4% acrylamide gel and separated at 80 V
until the dye hit the bottom. After electrophoresis, gels were dried and
exposed to Kodak X-ray ¢lm at 370‡C. Autoradiographic results
were evaluated quantitatively by an image analyzer. The binding
signal from each sample was measured in the same sized area. The
non-speci¢c binding was determined by adding at least 60-fold
excess of unlabeled DNA probes to the assay. Therefore, the speci¢c
binding was calculated by subtracting non-speci¢c binding from total
binding.
2.3.3. Bcl-2. Total RNA was extracted from the heart tissues by
the acid-guanidinium thiocyanate-phenol-chloroform method as de-
scribed previously [15]. For Northern blot analysis, total RNA was
electrophoresed in 1% agarose formaldehyde-formamide gel and
transferred to Gene Screen Plus hybridization transfer membrane (Bi-
otech Systems, NEN Research products, Boston, MA). The mem-
brane was then baked under vacuum at 80‡C for 1 h. Each hybrid-
ization was repeated at least three times using di¡erent membranes.
After each hybridization the residual cDNA was removed and rehy-
bridized with GAPDH cDNA probe, the results of which served as a
loading control. The autoradiograms were quantitatively evaluated by
computerized L scanner. The results of densitometric scanning were
normalized relative to the signal obtained using GAPDH cDNA.
2.4. Measurement of malonaldehyde (MDA) formation in heart
MDA was estimated in heart muscle to determine the development
of oxidative stress and free radical generation as described previously
[21]. In short, weighed heart biopsies were homogenized in 2 ml of
20% trichloroacetic acid, 5.3 mM sodium bisul¢te, kept on ice for 10
min, centrifuged at 3000Ug for 10 min, and then supernatants were
collected, derivatized with 2,4-dinitrophenylhydrazine (DNPH), and
extracted with pentane. Aliquots of 25 Wl in acetonitrile were injected
onto a Beckman Ultrasphere C18 (3 mm) column. The products were
eluted isocratically with a mobile phase containing acetonitrile-water-
acetic acid (40:60:0.1, v/v/v) and measured at three di¡erent wave-
lengths (307 nm, 325 nm and 356 nm) using a Waters M-490 multi-
channel UV detector. The peak for MDA was identi¢ed by co-chro-
matography with DNPH derivative of the authentic standard, peak
addition, UV pattern of absorption at the three wavelengths, and by
GC-MS.
2.5. Evaluation of apoptosis
To examine apoptosis, cardiomyocytes were obtained by established
methods [5]. Following experiments, hearts (control, ischemic, reper-
fused) were quickly placed into a chilled dissociation bu¡er containing
(mM): NaCl 137, KCl 5.4, CaCl2 1.8, MgCl2 1.0, KH2PO4 0.44,
Na2HPO4 0.34, dextrose 5.6, HEPES bu¡er (pH 7.5) 20 N, penicillin
50 U/ml, and streptomycin 50 Wg/ml. The ventricles were cut into 1^2
mm cubes and dissociated by trypsinization (0.05% trypsin-EDTA
at 37‡C for 10 min). Unfreed cells from the ¢rst treatment were
discarded, and the sequence was repeated until all tissue was disso-
ciated (approximately ¢ve times). Freed cells were collected in
cold Dulbecco’s modi¢ed Eagle’s medium (DMEM, Gibco BRL,
Gaithersburg, MD) supplemented with 0.5% fetal calf serum (FCS)
and 0.002% DNase, and washed in the same medium. The isolated
primary cardiac myocytes were used to evaluate DNA fragmenta-
tion.
Apoptotic cell death was evaluated using the TUNEL method using
APOP TAG kit (Oncor, Gaithersburg, MD). In brief, control, ische-
mic/reperfused, and adapted heart tissues were immediately put in
10% formalin and ¢xed in an automatic tissue ¢xing machine. The
tissues were carefully embedded in molten para⁄n in metallic blocks,
covered with £exible plastic moulds and kept under freezing plates to
allow the para⁄n to solidify. The metallic containers were removed
and tissues became embedded in para⁄n on the plastic moulds. Ten
sections were made from each sample in order to make a clear judge-
ment for each experiment. Prior to analyzing tissues for apoptosis,
tissue sections were depara⁄nized with xylene and washed in succes-
sion with di¡erent concentrations of ethanol (absolute, 95%, 70%).
Tissues were then treated with proteinase K for 15 min at room
temperature, excess liquids carefully blotted around the sections, 1U
equilibrium bu¡er was applied directly on the specimens, and the
specimens were placed in a humidi¢ed chamber for 5 min at room
temperature. Specimens were then treated with terminal deoxynucleo-
tidyl transferase (TdT) at 37‡C for 1 h in a humidi¢ed chamber. After
1 h, coverslips were removed, and the specimens were placed in a
Coplin jar containing stop/wash bu¡er (supplied in kit) for 10 min
at room temperature. 52 Wl of working strength anti-digoxigenin-£uo-
rescein was added to the slides and incubated for 30 min at room
temperature, washed in PBS, and counterstained with propidium io-
dide/antifade (supplied with kit) directly on the slide. Apoptotic cells
were visualized by direct £uorescence detection of digoxigenin-labeled
genomic DNA by epi£uorescence using standard £uorescein excita-
tion and emission ¢lters with an Axiovert 100 TV microscope. This
method was based on the new 3P-OH DNA end generated by DNA
fragmentation and typically localized in morphologically identi¢able
nuclei and apoptotic bodies. In contrast, normal nuclei, which had
relatively insigni¢cant numbers of DNA 3P-OH ends, were not stained
with this reagent.
To further characterize apoptosis, DNA was isolated from cardio-
myocytes by standard techniques. In brief, myocytes were pelleted in
an Eppendorf tube using 1000Ug for 2 min. The supernatant was
aspirated, 20 Wl of lysis bu¡er (10 mM EDTA, 0.5% sarcosyl, 50
mM Tris-HCl, pH 8.0) was added, vortexed and placed at 4‡C for
15 min. 1 Wl of proteinase K (stock solution 20 mg/ml) was added to
each sample. The samples were vortexed, and then incubated for 1 h
at 50‡C. After incubation for at least 1 h, 1 Wl of RNase A (stock
solution 10 mg/ml) was added and incubated for an additional hour at
37‡C. 5 Wl of gel loading bu¡er was added to the sample, and 10 Wl of
the DNA sample was electrophoresed on a 1.8% agarose gel with
ethidium bromide. DNA laddering was visualized and photographed
under ultraviolet transillumination.
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3. Results
3.1. E¡ects of PC and I/R on the consensus AP-1 binding
activity
Electrophoretic mobility shift assay indicated increased AP-
1 binding activity in the ischemic/reperfused rat heart (Fig. 1,
lane B) compared to the control perfused group (lane A).
DMTU inhibited this binding activity signi¢cantly as shown
in Fig. 1C. In ischemically adapted groups (both 1UPC and
4UPC), the binding activity of AP-1 did not exhibit any alter-
ation compared to baseline control (Fig. 1D,E). The binding
signal obtained from the image analyzer con¢rmed that AP-1
has greater binding activity in ischemic/reperfused rat hearts
compared to any other groups.
3.2. E¡ects of PC and I/R on nuclear translocation of NF-UB
NF-UB binding activity was found to be very low in non-
ischemic control hearts (Fig. 2A). Reperfusion of ischemic
myocardium moderately increased the translocation of NF-
UB from cytosol to nucleus (Fig. 2B). Perfusion of the heart
with DMTU inhibited NF-UB translocation from cytosol to
nucleus as shown in Fig. 2C. NF-UB binding activity was
increased signi¢cantly (5-fold) for the ischemically adapted
hearts when compared to the ischemic/reperfused myocardi-
um. For example, the binding increased slightly for 1UPC
hearts (Fig. 2D) and appreciably for 4UPC hearts (Fig.
2E). To con¢rm the speci¢city of NF-UB binding activity,
we performed supershift assays with polyclonal antibody rec-
ognizing NF-UB p65 subunit (results not shown).
3.3. E¡ects of PC and I/R on Bcl-2 mRNA expression
Northern blot analysis revealed Bcl-2 gene upregulation in
ischemically adapted hearts (1UPC, Fig. 3D; 4UPC, Fig. 3E)
compared to the control hearts (Fig. 3A). In contrast, pro-
longed reperfusion (2 h) after acute ischemia (30 min) down-
regulated Bcl-2 gene signi¢cantly as shown in Fig. 3B. Perfu-
sion of the hearts with DMTU increased Bcl-2 mRNA
activities (Fig. 3C).
3.4. E¡ects of PC and I/R on cardiomyocyte apoptosis
The number of apoptotic cells was signi¢cantly higher
(23%) in the ischemic/reperfused myocardium (Fig. 4B) com-
pared to the control hearts (Fig. 4A). DMTU signi¢cantly
reduced the number of apoptotic cells (Fig. 4C) compared
to ischemic/reperfused hearts (Fig. 4B). Myocardial adapta-
tion to ischemia reduced the number of apoptotic cells. For
1UPC hearts the extent of apoptotic cell death was reduced to
18% (Fig. 4D) while almost no apoptotic cells were noticed in
the 4UPC hearts (Fig. 4E).
3.5. E¡ects of PC and I/R on cardiomyocyte DNA laddering
DNA fragmentation was clearly visualized in the hearts
subjected to 30 min of ischemia followed by 2 h of reperfusion
(Fig. 5, lane C). DNA ladders were not apparent in the con-
trol hearts (Fig. 5, lane B). DMTU signi¢cantly reduced DNA
fragmentation when applied to the heart prior to ischemic
insult (Fig. 5, lane D). Ischemic adaptation was also associ-
ated with a decrease in DNA fragmentation. The extent of
inhibition was more in 4UPC (Fig. 5, lane F) than in 1UPC
(Fig. 5, lane E) hearts.
3.6. E¡ects of PC and I/R on MDA formation in heart
The production of MDA is an indicator for the develop-
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Fig. 3. Northern blot analysis of Bcl-2 mRNA. Northern blot anal-
ysis reveals the induction of Bcl-2 in preconditioned rat myocardi-
um. Total RNA was isolated and Northern hybridization was per-
formed as described in Section 2. Lane A: control; lane B:
ischemia/reperfusion; lane C: DMTU+ischemia/reperfusion; lane D:
1UPC+ischemia/reperfusion; lane E: 4UPC+ischemia/reperfusion.
Fig. 2. NF-UB binding activity in rat heart. Ischemia/reperfusion as
well as PC increases NF-UB translocation. Nuclear extracts were
isolated from control and experimental hearts. These extracts were
then used for electrophoretic mobility shift assay as described in
Section 2. Lane A: control; lane B: ischemia/reperfusion; lane C:
DMTU+ischemia/reperfusion; lane D: 1UPC+ischemia/reperfusion;
lane E: 4UPC+ischemia/reperfusion.
Fig. 1. AP-1 binding activity in rat heart. Ischemia/reperfusion stim-
ulates AP-1 binding activity in rat myocardium. Nuclear extracts
were isolated from control and experimental hearts. These extracts
were then used for electrophorectic mobility shift assay (EMSA) as
described in Section 2. Lane A: control; lane B: ischemia/reperfu-
sion; lane C: DMTU+ischemia/reperfusion; lane D: 1UPC+ische-
mia/reperfusion; lane E: 4UPC+ischemia/reperfusion.
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ment of oxidative stress. We have estimated the level of MDA
formation to monitor the extent of lipid peroxidation. As
shown in Fig. 6B, after 30 min of ischemia followed by 120
min of reperfusion, MDA content was 300 þ 10.5 pmol/g com-
pared to only 50 þ 6 pmol/g for the perfused hearts (Fig. 6A).
At the end of 2 h reperfusion, MDA content in the DMTU-
treated hearts was only 100 þ 8 pmol/g demonstrating that
DMTU lowered the oxidative stress in the heart. In the
1UPC group (Fig. 6D), MDA content at the end of the ex-
periment was 275 þ 11 pmol/g compared to 150 þ 9 pmol/g
MDA observed for the 4UPC group (Fig. 6E).
4. Discussion
The heart possesses a remarkable ability to adapt itself to
any stressful situation by increasing resistance to the adverse
consequences. Creating a stress reaction by repeated ischemia
and reperfusion or subjecting the hearts to heat or oxidative
stress enables the heart to meet the future stress challenge by
upregulating its cellular defense through direct accumulation
of intracellular mediators which constitute the material basis
of increased adaptation to stress. Thus, the powerful cardio-
protective e¡ect of adaptation is likely to originate at the
cellular and molecular levels. In this report, we demonstrate
that repeated cyclic episodes of ischemia and reperfusion re-
duced cardiomyocyte apoptosis and DNA fragmentation.
This was associated with the induction of the expression of
Bcl-2 mRNA and translocation and activation of NF-UB. An-
other transcription factor, AP-1, remained una¡ected by re-
peated ischemia and reperfusion, but exhibited signi¢cant up-
regulation by a single episode of 30 min ischemia followed by
2 h of reperfusion. This activation of AP-1 was inhibited by a
scavenger of oxygen free radicals, DMTU, when administered
prior to ischemia. Thirty minutes ischemia and 120 min re-
perfusion inhibited the induction of the expression of Bcl-2,
but activated NF-UB binding activity to some extent.
Ischemic preconditioning is the manifestation of the earlier
stress response that occurs during repeated episodes of brief
ischemia and reperfusion, and can render the myocardium
more tolerant to a subsequent potential lethal ischemic injury
[22,23]. This transient adaptive response has been demon-
strated to be associated with decreased reperfusion-induced
arrhythmias [24], increased recovery of postischemic contrac-
tile functions [25,26], and reduction of infarct size [27]. The
adaptive protection is believed to be mediated by gene expres-
sion and their transcriptional regulation [28^30]. Recent ¢nd-
ings indicate that multiple kinases including MAP kinases and
MAPKAP kinase 2 are likely to be involved in the adaptive
signaling process [31^33]. The acutely developing adaptive ef-
fect is short-lived, lasting for only up to 2^3 h. Hearts can
subsequently undergo a secondary and delayed adaptation to
stress presumably through the induction of the expression of
new genes and their subsequent translation into proteins. A
number of genes and proteins have been identi¢ed as possibly
involved in the development of delayed preconditioning in-
cluding heat shock proteins, superoxide dismutase, catalase,
nitric oxide synthase as well as ATPase 6 and cytochrome b
subunits [31]. Such an adaptive response becomes evident only
after approximately 24 h of stress treatment and may include
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Fig. 6. Estimation of MDA production by HPLC. Control and ex-
perimental hearts were processed, MDA extracted and derivatized
with DNPH as described in Section 2. MDA formation is shown by
bar graphs. Results are expressed as means þ S.E.M of six rats per
group. *P6 0.05 vs. baseline control, 2P6 0.05 compared to ische-
mic/reperfused control. A: control; B: ischemia/reperfusion; C:
DMTU+ischemia/reperfusion; D: 1UPC+ischemia/reperfusion; E:
4UPC+ischemia/reperfusion.
Fig. 5. DNA fragmentation in ischemic/reperfused heart. DNA frag-
mentation was increased in the ischemic/reperfused myocardium.
Cardiomyocytes were isolated and DNA was extracted from control
and experimental rat myocardium as described in Section 2. Lane
A: DNA marker; lane B: control; lane C: ischemia/reperfusion;
lane D: DMTU+ischemia/reperfusion; lane E: 1UPC+ischemia/re-
perfusion; lane F: 4UPC+ischemia/reperfusion.
Fig. 4. Evaluation of apoptosis by the TUNEL method. Evaluation
of apoptosis reveals an increased number of apoptotic cells in the is-
chemic/reperfused myocardium. Sections of control and experimental
heart tissues were analyzed for apoptosis using APOP TAG kit as
described in Section 2. Percent apoptotic cells is shown by bar
graphs. Results are expressed as means þ S.E.M of six rats per
group. *P6 0.05 vs. baseline control, 2P6 0.05 compared to ische-
mic/reperfused cntrol. A: control; B: ischemia/reperfusion; C:
DMTU+ischemia/reperfusion; D: 1UPC+ischemia/reperfusion; E:
4UPC+ischemia/reperfusion.
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stress induced by heat shock, oxidant or other stress-inducible
agents. MAPKAP kinase 2 appears to link the early precon-
ditioning e¡ect to the delayed adaptive response [34].
Our laboratory demonstrated that ischemic preconditioning
triggers a signaling pathway by potentiating tyrosine kinase
phosphorylation [34]. The signal transduction involves phos-
pholipase D which subsequently transmits the signal via the
activation of MAP kinases. Our results clearly indicated a role
of tyrosine kinase, because inhibition of tyrosine kinase phos-
phorylation by genistein almost completely blocked the acti-
vation of protein kinase C, MAP kinases and MAPKAP kin-
ase 2. Subsequently, we were able to identify p38 MAP kinase
as one of the potential targets for tyrosine kinase phospho-
rylation. A role of tyrosine kinase and p38 MAP kinase in
ischemic adaptation has been supported by other investigators
[35,36]. For example, a correlation was found between p38
MAPK phosphorylation and protection by preconditioning,
suggesting that its activation might represent a crucial step
in the signal transduction cascade of ischemic precondition-
ing. In this study, the investigators showed that simulated
preconditioning in isolated rabbit cardiomyocytes was pre-
vented by SB203580 and was mimicked by the p38-MAPK/
JNK activator, anisomycin [35]. An inhibitor of tyrosine kin-
ase, genistein, blocked the myocardial adaptation to ischemia
[36].
Studies from di¡erent laboratories including our own dem-
onstrated that reperfusion of ischemic myocardium results in
cardiomyocyte apoptosis in addition to necrosis. We have
shown that a hallmark of apoptosis, translocation of phos-
phatidyl serine and phosphatidyl ethanolamine, occurs during
ischemia, but execution of apoptosis does not occur until the
late phase of reperfusion [5]. Oxidative stress developed in the
ischemic/reperfused myocardium was found to be instrumen-
tal for apoptotic cell death [9]. Another related study showed
that myocardial adaptation to ischemia provided cardiopro-
tection by blocking apoptotic cell death [6]. Prolonged reper-
fusion after ischemia caused downregulation of the antioxi-
dant gene, Bcl-2, in concert with enhanced DNA
fragmentation [17].
Evidence is rapidly accumulating to support the notion that
oxygen-derived free radicals are involved in transmembrane
signaling processes. In a recent study, a tyrosine kinase inhib-
itor, herbimycin A, and a free radical scavenger, N-acetylcys-
teine, were found to inhibit free radical-induced activation of
NF-UB indicating that activation triggered by reactive oxygen
species is dependent on tyrosine kinase activity [37]. A large
number of studies from di¡erent laboratories including our
own showed the induction of the expression of antioxidant
genes during preconditioning [28]. Our recent study on the
role of NF-UB in tyrosine kinase signaling of ischemic adap-
tation and MAPKAP kinase 2 phosphorylation supports
these earlier ¢ndings [11]. Existing evidence that oxidative
stress/free radicals lead to the activation of NF-UB thereby
inducing the expression of genes also supports the role of
reactive oxygen species as messenger molecules [37,38].
A signi¢cant amount of evidence exists in the literature
indicating a crucial role of oxygen free radicals in myocardial
ischemia/reperfusion injury. The presence of reactive oxygen
species, especially hydroxyl radical (OHc), in the ischemic/re-
perfused heart has been demonstrated both directly [39] and
indirectly [40]. It is possible that OHc radical formed by tran-
sient metal-catalyzed Fenton reaction during the reperfusion
of ischemic heart [41] induced NF-UB activation. Inhibition of
NF-UB translocation and AP-1 induction by DMTU, a OHc
scavenger, further supports a role of free radicals as a signal-
ing molecule.
The most interesting ¢nding of this study is that both AP-1
and NF-UB are activated after 30 min ischemia followed by 2 h
of reperfusion. Such activation of AP-1 and NF-UB was
blocked by scavenging the reactive oxygen species suggesting
that the activation of these transcription factors is mediated
by oxidative stress. Myocardial adaptation induced by cyclic
episodes of short-term ischemia and reperfusion results in the
activation of NF-UB by 5-fold, while AP-1 remained unaf-
fected. Interestingly, the Bcl-2 gene is downregulated after
30 min ischemia and 2 h reperfusion, but induced signi¢cantly
after 5 min ischemia/10 min reperfusion and further enhanced
after four cyclic episodes of ischemia and reperfusion. In con-
cert, MDA formation, a presumptive marker for oxidative
stress, which is increased after the initial phase of ischemia/
reperfusion, decreased after ischemic adaptation. Cardiomyo-
cyte apoptosis and DNA fragmentation also increased after
prolonged reperfusion, but decreased after ischemic adap-
tation.
In the majority of cells, NF-UB exists as a cytoplasmic
complex by binding with its inhibitory protein IUB. Phosphor-
ylation of IUB by oxidative stress induced by ischemia/reper-
fusion can cause dissociation from NF-UB. We have shown
moderate translocation of NF-UB in the ischemic/reperfused
heart and signi¢cant translocation in the preconditioned heart
from the cytosol to the nucleus by EMSA assay. We have also
investigated the loss of IUB protein after dissociation in the
cytoplasm caused by ischemia/reperfusion and precondition-
ing. The kinetics of NF-UB binding activity in the nuclear
extracts correlate with the kinetics for IUBK protein disap-
pearance in the cytoplasm. The data (not shown) suggest
that the disappearance of IUBK protein from cytoplasm re-
sulted in the translocation of the NF-UB complex to the nu-
cleus as an active form.
Preconditioning of the ischemic myocardium increased the
extent of NF-UB translocation (Fig. 2, lane E) to a greater
extent than ischemia and reperfusion (Fig. 2, lane B). In con-
cert, Bcl-2 gene expression in the ischemic reperfused myocar-
dium was signi¢cantly reduced (Fig. 3, lane B) when com-
pared to the preconditioned heart (Fig. 3, lane E).
Therefore, when the extent of NF-UB translocation is signi¢-
cantly elevated in the preconditioned heart, signi¢cant up-
regulation of Bcl-2 also occurs.
The results of our study indicate a direct role of AP-1 on
cardiomyocyte apoptosis. Reperfusion of ischemic myocardi-
um results in the activation of AP-1 simultaneously causing
apoptotic cell death. Conversely, ischemic stress adaptation
downregulates AP-1 in concert with the attenuation of apop-
tosis. These results receive support from the previous obser-
vations that increased expression of components of AP-1 is
linked to apoptosis [42^44]. A recent study demonstrated that
c-Jun/AP-1, but not NF-UB, is a mediator for oxidant-initi-
ated apoptosis in glomerular mesangial cells [45]. In this
study, using Northern blot analysis and transient transfection
assays with reporter plasmids, the authors showed that H2O2
activated both AP-1 and NF-UB. Downregulation of c-Jun/
AP-1 using a transdominant negative mutant of c-Jun inhib-
ited apoptotic cell death while use of a transdominant nega-
tive mutant of p50 NF-UB subunits did not a¡ect H2O2-medi-
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ated apoptosis. Our study showed activation of both AP-1,
but the anti-apoptotic signal induced by ischemic adaptation
did not alter AP-1. NF-UB, on the other hand, was slightly
activated after ischemia/reperfusion, but signi¢cantly activated
during ischemic stress adaptation. A previous study demon-
strated that activation of NF-UB is a necessary step for my-
ocardial adaptation to ischemic stress. Taken together, the
present results suggest that activation of NF-UB during
ischemic adaptation is associated with a decrease in cardio-
myocyte apoptosis when AP-1 remains downregulated at the
baseline level. In contrast, an increase in AP-1 during
ischemia/reperfusion is associated with cardiomyocyte apop-
tosis when NF-UB remains signi¢cantly downregulated com-
pared to that in the preconditioned heart.
In summary, to the best of our knowledge, the present
¢ndings demonstrated for the ¢rst time di¡erential regulation
of AP-1, NF-UB and the Bcl-2 gene in myocardial adaptation
to ischemia. Ischemic adaptation resulted in reduced oxidative
stress, decreased apoptosis and unchanged AP-1 binding ac-
tivity, but increased NF-UB and upregulation of the Bcl-2
gene. Analysis of these seemingly con£icting data suggests
that while both AP-1 and NF-UB are induced through the
oxidative stress developed in the ischemic/reperfused myocar-
dium, cardiomyocyte apoptosis occurs when AP-1 remains
high and NF-UB remains low as in the case of ischemia/re-
perfusion. Cardiomyocyte death due to apoptosis remains low
when NF-UB binding activity is high and AP-1 is low as in the
case of ischemic preconditioning. The Bcl-2 gene is decreased
after prolonged reperfusion (2 h) following an acute ischemic
insult (30 min), but it becomes upregulated by ischemic adap-
tation. The results of this study also suggest that oxygen free
radicals play a role in the signal transduction process triggered
by ischemic adaptation.
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